Endocrine-disrupting chemicals are a significant concern to public health.
Differences in surgical management, in adjuvant therapy, and in patient populations seem to have no effect on the high 3-year survival and 3-year recurrence-free survival rates associated with preoperative grade 1 endometrial cancer.
Researchers from Duke University and Toronto Sunnybrook Regional Cancer Center performed a retrospective analysis involving 494 women from the two institutions identified with preoperative, central-review–confirming, grade 1, endometroid, endometrial cancer.
While the two groups of women were similar in grade, final histology, type of hysterectomy, and length of hospital stay, the women from Sunnybrook were a few years older (aged 62 years compared with 59 years at Duke), were more than twice as likely as the women at Duke to have capillary lymphatic space involvement (18.2% vs. 8.3%, respectively), were more than three times as likely as the women at Duke to have cervical involvement (12.2% vs. 3.7%, respectively), were less likely than the women at Duke to have been operated on by a gynecologic oncologist (66% vs. 91%, respectively), and were three times more likely than their counterparts to receive adjuvant radiation treatment (20.7% vs. 7%, respectively).
Bernardini MQ, May T, Khalifa MA, et al. Evaluation of two management strategies for preoperative grade 1 endometrial cancer. Obstet Gynecol. 2009;114:7-15.
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
Personalized opioid protocol for cesarean deliveries: Reduced prescriptions reported
April 19th 2024A recent suggests that implementing a personalized opioid prescription protocol significantly reduces total morphine milligram equivalents and the number of opioid tablets prescribed at discharge following cesarean delivery.
Read More
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More